|
|
||||||||
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
Accepted for publication July 10, 2008.
* Address correspondence to Dr Jiang, Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, 507 Zhengmin Rd, Shanghai, 200433, China (Email: jgnwp{at}yahoo.com.cn).
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a challenge to TB control, and surgical resection is regaining its status as an integral component of multimodal treatment. We evaluated the efficacy and risks of pulmonary resection in the treatment of MDR-TB.
Methods: A retrospective review was performed of 56 patients who had undergone pulmonary resection for MDR-TB from January 1995 to July 2006. Preoperative diagnoses included cavitation in 25 patients, lung destruction in 17, endobronchial TBs in 10, and tuberculoma in 4.
Results: Mycobacterium tuberculosis resistant to both isoniazid and rifampin was isolated from the sputum of all patients preoperatively but in only 5 patients postoperatively. Pneumonectomy was performed on 25 patients and lobectomy on 31. No patients died perioperatively, but major complications occurred in 14 patients, with a morbidity of 25%. Complications included reoperation due to uncontrollable postoperative bleeding in 1 patient, chylothorax in 1, wound infection in 1, bronchopleural fistula in 9, and chronic tuberculous empyema in 2. Analysis of variance showed that lung function was significantly correlated with the type of preoperative diagnosis. Univariate and multivariate logistic regression analyses revealed that endobronchial TB significantly contributed to the development of bronchopleural fistula, and bronchial stump reinforcement could prevent its occurrence.
Conclusions: Pulmonary resection plays an important role in the treatment of MDR-TB. Endobronchial TB is a significant risk factor for developing bronchopleural fistula, but bronchial stump reinforcement can effectively prevent its occurrence.
This article has been cited by other articles:
![]() |
L. Bai, Z. Hong, C. Gong, D. Yan, and Z. Liang Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs Eur J Cardiothorac Surg, February 1, 2012; 41(2): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Xu, R.-H. Jiang, and L. Li Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis J. Antimicrob. Chemother., August 1, 2011; 66(8): 1687 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Yew, C. Lange, and C. C. Leung Treatment of tuberculosis: update 2010 Eur. Respir. J., February 1, 2011; 37(2): 441 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |